Page last updated: 2024-10-31
metyrapone and Pancreatic Diseases
metyrapone has been researched along with Pancreatic Diseases in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Pancreatic Diseases: Pathological processes of the PANCREAS.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| STAFFIERI, JJ | 1 |
| LENCIONI, LJ | 1 |
| EBERHARDT, DR | 1 |
| GORNI, DL | 1 |
Other Studies
1 other study available for metyrapone and Pancreatic Diseases
| Article | Year |
|---|---|
[HYPOGLYCEMIC SYNDROME DUE TO HYPERFUNCTIONING ISLET CELL ADENOMA].
Topics: Adenoma, Islet Cell; Clinical Laboratory Techniques; Glucose Tolerance Test; Humans; Hyperinsulinism | 1963 |